05-05-2020
markvanscyoc / Shutterstock.com
The US Patent and Trademark Office (USPTO) has launched a platform aimed at supporting patent owners wanting to license technology related to the “prevention, treatment, and diagnosis” of COVID-19.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
USPTO, COVID-19, coronavirus, patent platform, licensing, patent licensing, Patents 4 Partnerships, technology
Biden backs TRIPS waiver for COVID-19 vaccines
06-05-2021
USPTO announces COVID-19 deferred-fee patent application programme
18-09-2020
UKIPO extends ‘interrupted days’; Fed Circuit increases phone hearings
12-05-2020
IP offices extend deadlines amid pandemic
04-05-2020
South Korea is tracking COVID-19 patent data to tackle fake treatments
25-03-2020
